Novo Integrated Sciences, Inc. (NVOS)

Novo Integrated Sciences Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Year Ending	TTM	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Cash & Equivalents	1.54	0.42	2.18	8.29	2.07	2.08
Cash & Cash Equivalents	1.54	0.42	2.18	8.29	2.07	2.08
Cash Growth	231.84%	-80.89%	-73.73%	301.08%	-0.77%	208.37%
Receivables	3.3	2.52	2.1	2.98	2.32	2.83
Inventory	1.11	1.11	0.88	0.34	0	0
Other Current Assets	0.21	0.35	0.57	-0.47	-0.1	-0.81
Total Current Assets	6.16	4.39	5.73	11.13	4.29	4.1
Property, Plant & Equipment	6.95	7.37	8.47	8.61	3.16	3.41
Goodwill and Intangibles	22.21	23.8	26.67	41.52	27.26	22.98
Other Long-Term Assets	0	0	0	0.69	0.67	1.78
Total Long-Term Assets	29.17	31.17	35.14	50.82	31.1	28.17
Total Assets	35.33	35.56	40.87	61.96	35.39	32.27
Accounts Payable	4.16	4.05	2.28	1.93	1.41	2.06
Current Debt	2.64	2.18	9.69	5.04	0.65	0.51
Other Current Liabilities	15.88	1.68	2.1	1.5	0.54	0.45
Total Current Liabilities	22.68	7.9	14.07	8.46	2.6	3.03
Long-Term Debt	1.6	1.76	3.31	8.19	3.22	3.7
Other Long-Term Liabilities	1.39	1.4	1.45	1.5	0	0
Total Long-Term Liabilities	2.99	3.16	4.75	9.69	3.22	3.7
Total Liabilities	25.66	11.06	18.83	18.15	5.82	6.73
Total Debt	4.24	3.94	13	13.23	3.87	4.21
Debt Growth	1.64%	-69.69%	-1.77%	242.20%	-8.17%	162.08%
Retained Earnings	-88.2	-67.03	-53.82	-20.97	-16.51	-11.59
Comprehensive Income	1.45	-0.36	0.56	0.99	1.2	1.14
Shareholders' Equity	9.96	24.82	22.31	43.86	29.62	25.58
Net Cash / Debt	-2.7	-3.52	-10.82	-4.94	-1.8	-2.13
Net Cash Per Share	-0.14	-0.35	-3.71	-1.99	-0.78	-0.98
Working Capital	-16.52	-3.52	-8.34	2.67	1.69	1.07
Book Value Per Share	0.53	2.44	7.66	17.71	12.86	11.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).